This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Martin John Slater: Innovator in Anti-Viral Treatments
Introduction
Martin John Slater is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of anti-viral agents, particularly in the treatment of viral infections. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry significantly.
Latest Patents
Slater's latest patents include innovative compounds such as 1-acyl-pyrrolidine derivatives for the treatment of viral infections. These anti-viral agents are characterized by a specific formula where various components represent different chemical structures. His work also includes 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives, which serve as inhibitors for Hepatitis C Virus (HCV). These novel anti-viral agents are designed to provide effective treatment options for patients suffering from viral infections.
Career Highlights
Throughout his career, Martin John Slater has worked with prominent companies in the pharmaceutical sector, including Glaxo Group Limited and GlaxoSmithKline LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.
Collaborations
Slater has collaborated with notable colleagues such as Pritom Shah and David Haigh. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Martin John Slater is a distinguished inventor whose work in anti-viral treatments showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of innovation in addressing global health challenges.